Terbutaline for the treament of painful neuropathy

Phase 1

• Conditions: Painful polyneuropathy; MedDRA version: 18.0Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 100000004852; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2015-002984-40-DK
• Lead Sponsor: Department of Neurology, Odense University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-10
• Last Update Posted: 1 February 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 58

Inclusion Criteria

- age over 18 years
- pain due to polyneuropathy for more than 3 months
- pain score 4 or higher on 0-10 point numeric rating scale
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 28

Exclusion Criteria

- other sgnificant pain condition
- other significant neurological or psychiatric disease
- known allergic reactions or other significant adverse events on the study drugs
- significant heart, lung, kidney or liver disease
- treatment with drugs that interact significantly with the study drugs

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified